Onconova Therapeutics Stock Price - ONTX

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Pre-Market
Last Trade
Last $ 0.30 ▲ 0.00 (0.51%)
Company Name Stock Ticker Symbol Market Type
Onconova Therapeutics Inc ONTX NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 0.2935 0.00 0.00 0.00 0.2935 06:49:16
Bid Price Ask Price Spread Spread % News
0.30 0.3071 0.0071 2.31% - -
Stock Trades Traded Volume Average Volume 52 Week Range
7 10,217 12,227,946 0.1027 - 5.25
Last Trade Time Type Quantity Stock Price Currency
06:49:16 1 $ 0.2992 USD

Onconova Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 11.28M 38.45M $ -20.57M -7.93 - 36.94M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 15.00 3.90%

more financials information »

Onconova Therapeutics News

Date Time Source News Article
12/10/201915:07GlobeNewswire Inc.Onconova Therapeutics, Inc. Announces Closing of $5.0..
12/10/201911:20Edgar (US Regulatory)Current Report Filing (8-k)
12/10/201908:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
12/09/201909:08Edgar (US Regulatory)Current Report Filing (8-k)
12/09/201909:00GlobeNewswire Inc.Onconova Therapeutics Announces Data on Genomic Profiles of..
12/09/201908:00GlobeNewswire Inc.Onconova Therapeutics, Inc. Announces $5.0 Million..
12/06/201916:06Edgar (US Regulatory)Current Report Filing (8-k)

Latest ONTX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ONTX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.300.5050.25510.331138124,650,906-0.0065-2.17%
1 Month0.350.770.10270.263824823,084,485-0.0565-16.14%
3 Months1.751.860.10270.29003367,520,730-1.46-83.23%
6 Months3.424.000.10270.31596983,610,263-3.13-91.42%
1 Year3.335.250.10270.38749911,895,556-3.04-91.19%
3 Years37.0558.200.10274.811,007,269-36.76-99.21%
5 Years58.50122.550.10277.31668,926-58.21-99.5%

Onconova Therapeutics Description

Onconova Therapeutics Inc is a clinical-stage biopharmaceutical company operating in the US. It focuses on discovering and developing novel small molecule product candidates primarily to treat cancer. The company has created a library of targeted agents designed to work against cellular pathways important to cancer cells. Its product candidates are Single-agent IV rigosertib, Oral rigosertib + azacitidine, IV Briciclib, Recilisib, and ON 123300. The key product candidate Rigosertib is a small molecule which blocks cellular signaling by targeting RAS effector pathways.
Your Recent History
NASDAQ
ONTX
Onconova T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191212 12:06:24